| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $309.4M | +27.4% |
| Cost of Revenue | $333.4M | +38.4% |
| Gross Profit | -$24.0M | -1269.2% |
| R&D Expense | $63.6M | +45.2% |
| SG&A Expense | $133.2M | +55.2% |
| Operating Income | -$220.9M | -73.0% |
| Pre-tax Income | -$237.9M | +4.8% |
| Income Tax | $0 | -100.0% |
| Net Income | -$237.9M | +4.8% |
| EPS (Basic) | -$1.06 | +48.8% |
| EPS (Diluted) | -$1.08 | +47.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.7M | -56.7% |
| Short-term Investments | $224.4M | -54.3% |
| Accounts Receivable | $130.3M | +59.6% |
| Inventory | $169.6M | +48.0% |
| Current Assets | $665.7M | -24.9% |
| Total Assets | $840.5M | -14.4% |
| Current Liabilities | $251.0M | +172.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$296.6M | -134.9% |
| Capital Expenditures | $59.5M | +153.8% |
| Investing Cash Flow | $184.1M | +141.2% |
| Financing Cash Flow | $16.2M | -97.4% |
| Free Cash Flow | -$356.1M | -137.9% |
| Long-term Debt |
| $122.7M |
| +10.5% |
| Total Liabilities | $323.6M | +23.6% |
| Stockholders' Equity | $516.9M | -28.2% |